Bioplax Italia S.r.l. is a company specializing in the development of innovative solutions for oral health.

The company’s approach is driven by research, innovation and scientific development, with a strong focus on the quality, safety and efficacy of its products. Bioplax’s key strengths include international patents, product registrations in several countries, clinical and scientific evidence.

Bioplax conceived and developed Aftamed^® for the management of oral ulcers and Aftamed^® Teething to relieve gum and oral inflammation typical of infancy. Aftamed^® are medical devices compliant with the EU Medical Device Regulation (MDR).

More recently, Bioplax developed Aftamed^® Periodontal, an innovative cosmetic treatment formulated to support gingival and oral health in cases of occasional bleeding and inflammation.

Today, Aftamed^® is successfully distributed in several European and international markets.